Logo for EpiBone

Meet an Unreasonable Venture


Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.

Photo of Nina Tandon

Nina Tandon

CEO & Co-Founder at EpiBone

More about Nina »
Employees 21–50
Headquarters New York, New York, United States
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Currently Operating in One Region

Press Mentions

October 17, 2015

Why Peter Thiel Invested In New York Biotech Startup EpiBone

Read on Inc.com »

More Ventures in Health

Get the Unreasonable Newsletter

Get twice-monthly updates on EpiBone and over 349 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.